Indian Medtech Welcomes India-NZ FTA But Calls CDSCO Exclusion A Strategic Gap

The India-New Zealand FTA is not India's only recent trade agreement with consequences for the medical device sector.
The absence of CDSCO from the framework means that Indian manufacturers whose products are approved under the Indian regulatory pathway rather than an overseas equivalent will not automatically benefit from the expedited recognition provisions in the agreement. Picture Courtesy: Shutterstock

More from Strategy

More from Business